Presentation Information
[P03-432]Engineered probiotic bacteria producing an RNA-based TLR7/8 agonist for enhanced cancer immunotherapy
Hyungjin Sun1, ○Jinyoung Kim2, Pyunghwajun Lee1, Sang Woo Seo1,2,3,4,5, Junsang Doh1,4,6,7 (1. Interdisciplinary Program in Bioengineering, Seoul National University (Korea), 2. Department of Chemical and Biological Engineering, Seoul National University (Korea), 3. Institute of Chemical Processes, Seoul National University (Korea), 4. Bio-MAX Institute, Seoul National University (Korea), 5. Institute of Bio Engineering, Seoul National University (Korea), 6. Department of Materials Science and Engineering, Seoul National University (Korea), 7. Research Institute of Advanced Materials, Seoul National University (Korea))
Keywords:
Cancer immunotherapy,Synthetic biology,TLR7/8 agonist,Engineered probiotic bacteria,Immune activation
Comment
To browse or post comments, you must log in.Log in
